Wear face masks with no metal during MRI exams. | PSNet

Provide Feedback |

Register

Press Release/Announcement

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA Safety Communication. MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; December 7, 2020.

Magnetic resonance imaging (MRI) requires patient preparation steps to protect against inadvertent harm. This announcement cautions patients and providers to assess masks being worn to protect against COVID-19 transmission for metal components that can result in patient burns during the exam. Recommendations for safety include enhanced screening to ensure masks are safe for the exam environment.

Related Resources From the Same Author(s)

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents.

July 15, 2020

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning.

March 4, 2015

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

View More

Related Resources

COVID-19 in Nursing Homes: CMS Needs to Continue to Strengthen Oversight of Infection Prevention and Control.

October 12, 2022

Mapping the resilience performance of community pharmacy to maintain patient safety during the Covid-19 pandemic.

February 16, 2022

Nursing strategies to safeguard COVID-19 patients from harm in the intensive care unit.

December 8, 2021

Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: a cohort study.

November 10, 2021

Coronavirus Commission for Safety and Quality in Nursing Homes.

March 10, 2021

Using ventilator splitters during the COVID-19 pandemic--letter to health care providers.

February 17, 2021

Telehealth in the COVID-19 era: a balancing act to avoid harm.

February 17, 2021

Health Worker Safety: A Priority for Patient Safety.

September 30, 2020

FDA Advise-ERR: reported medication errors with Veklury (remdesivir) emergency use authorization.

September 23, 2020

Ensuring Healthcare Safety Throughout the COVID-19 Pandemic.

June 10, 2020

View More

See More About The Topic

Ambulatory Care

Facility and Group Administrators

Infectious Diseases

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364